| Project/Area Number |
16592012
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Kyushu Dental College |
|---|
Principal Investigator |
SHIIBA Shunji Kyushu Dental College, Associate professor, 歯学部, 講師 (20285472)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NAKANISHI Osamu Kyushu Dental College, Professor, 歯学部, 教授 (50137345)
SAKAMOTO Eiji Kyushu Dental College, Associate professor, 歯学部, 助手 (00295859)
|
|---|
| Project Period (FY) |
2004 – 2005
|
| Project Status |
Completed (Fiscal Year 2005)
|
| Budget Amount *help |
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2005: ¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 2004: ¥1,400,000 (Direct Cost: ¥1,400,000)
|
|---|
| Keywords | Neuropathic pain / GDNF / Inflammatory cytokine / CFA / Dorsal Root Ganglion / Sciatic nerve / Neuritis |
|---|
| Research Abstract |
It was clear. that painful animal model, CFA (complete Freund's adjuvant) and CCI (chronic constriction injury) in sciatic nerve induced neuropathic pain. The pain-related behavior which these models lick hindpow and take escape behavior for heat radiation and a pin prick test. That these pain-related action is inhibited by administration of thalidomide of immunomodulator and cyclosporine S of an immunosuppressive drug, and a substance of inflammatory contributes to neuropathic pain is predicted. Therefore I paid attention to GDNF which contributed to neurotization deeply. I understood that a pain-related behavior for all algetic irritation was inhibited when I preloaded an antibody of GDNF. GDNF developed in rat dorsal root ganglia, spinal dorsal root and nerve injury region from the immediately after which nerve damage caused. I became a peak after nerve damage in three days and continued it to 14 after a disorder. This immunostaining result accords with course of rat pain-related behavioral degree. Rat sciatic nerve exposed was soaked into GDNF solution, and it developed a pain-related behavior as CFA and CFA painful model. Intervention of GDNF to neuropathic pain became clear. Early administration of an GDNF blocker after nerve injury is effective as a therapy of neuropathic pain.
|
